AGP treatment at a dose of 1 uM for 48 h, resulted in an increased proliferation of human peripheral blood mononuclear cells (PBMCs), which up-regulate IL2 production and increased immune response against a wide range of cancers, including colorectal cancer (Varma et al., 2011). Here, ATP5MK is linked to colorectal cancer.